Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 22, 2025 • 6:01 PM ET

Date/Time Source News Release
03/02/2023 11:32 AM EST Business Wire Sesen Bio Stockholders Approve Merger with Carisma Therapeutics
02/28/2023 08:00 AM EST Business Wire Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results
02/21/2023 09:00 AM EST Business Wire Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote "FOR" All Proposals to Approve Pending Merger With Carisma
02/16/2023 04:42 PM EST Business Wire Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote "FOR" All Proposals at March 2 Special Meeting
02/16/2023 08:54 AM EST GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TIG, SESN, CINC, AJRD
02/16/2023 08:00 AM EST Business Wire Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Merger
02/15/2023 08:00 AM EST Business Wire BML, One of Sesen Bio's Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics
02/14/2023 08:00 AM EST Business Wire Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger
02/09/2023 10:45 AM EST PR Newswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SESN, LMST, SAL
02/02/2023 04:30 PM EST Business Wire Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger
Page

Additional News

As of July 22, 2025 • 6:01 PM ET

Date/Time Source News Release
03/02/2023 06:30 PM EST SeekingAlpha Sesen Bio stockholders approve 1-for-20 reverse stock split
03/02/2023 02:54 PM EST SeekingAlpha Sesen Bio (SESN) Investor Presentation - Slideshow
03/02/2023 12:03 PM EST SeekingAlpha Sesen Bio wins shareholder approval for Carisma merger
02/28/2023 08:23 AM EST SeekingAlpha Sesen Bio GAAP EPS of -$0.04 beats by $0.07
02/14/2023 08:48 AM EST SeekingAlpha Sesen gains 11% on amended terms for merger with Carisma
01/10/2023 01:42 AM EST SeekingAlpha ImmunityBio Isn't Assured Of Bringing Relief For Bladder Cancer
01/05/2023 06:50 AM EST ACCESSWIRE IA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TIG, SESN, CBIO
01/04/2023 11:49 AM EST SeekingAlpha Sesen Bio board reiterates desire to merge with Carisma Therapeutics
01/03/2023 04:18 PM EST SeekingAlpha Sesen Bio investors reiterate plan to vote against Carisma merger
01/02/2023 07:07 AM EST SeekingAlpha Organigram And Rounding Out My Tax Loss Selling Basket
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.